Mild To Moderate Erectile Dysfunction Study

Completed · Phase 4

Conditions studied: Impotence

In brief

Safety/Efficacy of 100-mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction

Key facts

Study ID

NCT00137072

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

355

Starts

2005-04-01

Expected to finish

2006-02-01

Last updated by the study team

2021-02-01

Who can join

Age: 18 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men 18-70 years of age
• Documented clinical diagnosis of erectile dysfunction of at least 3 months duration.

You may not qualify if…

• Subjects with penile implants
• Subjects with a known history of retinitis pigmentosa.
• Subjects, due to the requirement of 100 mg dosage, who are receiving concomitant treatment with the potent CYP3A4 inhibitor ritonavir.

Where it is running

• Pfizer Investigational Site — Hoover, Alabama, United States
• Pfizer Investigational Site — Huntsville, Alabama, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — La Mesa, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Middlebury, Connecticut, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — South Miami, Florida, United States
• Pfizer Investigational Site — Tallahassee, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Fort Wayne, Indiana, United States
• Pfizer Investigational Site — Jeffersonville, Indiana, United States
• Pfizer Investigational Site — Des Moines, Iowa, United States
• Pfizer Investigational Site — New Orleans, Louisiana, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Hattiesburg, Mississippi, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Bay Shore, New York, United States
• Pfizer Investigational Site — Kingston, New York, United States
• Pfizer Investigational Site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.